Registry for hip and knee joint implants and revisions
Endoprosthesis Registry Heidelberg (EPR-HD): Registry for the Analysis of Patients Following Primary Implantation or Revision Surgery of Artificial Joints in Hip and Knee Joint Pathologies
This study collects information from patients who have had hip or knee joint replacements to see how well the implants work over time and to improve future surgeries.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital Heidelberg Academic / other |
| Locations | 1 site (Heidelberg, Baden-Wurttemberg) |
| Trial ID | NCT06850818 on ClinicalTrials.gov |
What this trial studies
The Endoprosthesis Registry Heidelberg (EPR-HD) systematically collects and analyzes data from patients undergoing primary or revision surgeries of artificial hip and knee joints. It aims to evaluate long-term outcomes, complication rates, implant survival, and functional results associated with joint replacement procedures. By gathering comprehensive clinical data, the registry seeks to improve understanding of patient outcomes and identify factors influencing implant success, ultimately supporting evidence-based improvements in surgical techniques and patient care. Data will be collected at multiple time points during routine clinical follow-up at Heidelberg University Hospital.
Who should consider this trial
Good fit: Ideal candidates for this registry are adult patients undergoing primary or revision hip or knee arthroplasty due to conditions like osteoarthritis.
Not a fit: Patients who may not benefit from this registry include those who are underage or unable to provide informed consent.
Why it matters
Potential benefit: If successful, this registry could lead to improved surgical strategies and better long-term outcomes for patients undergoing hip and knee joint replacements.
How similar studies have performed: Other similar registries have shown success in improving patient outcomes and understanding implant performance, making this approach well-supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients undergoing hip or knee arthroplasty at our institution * All patients undergoing revision surgery following hip oder knee arthroplasty Exclusion Criteria: * Lack of prospective consent for study participation * Lack of capacity to provide informed consent * Minor status (underage)
Where this trial is running
Heidelberg, Baden-Wurttemberg
- University Hospital Heidelberg — Heidelberg, Baden-Wurttemberg, Germany (Recruiting)
Study contacts
- Study coordinator: Mustafa Hariri, MD
- Email: mustafa.hariri@med.uni-heidelberg.de
- Phone: 004962215635652
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.